亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Enhancing Preventative and Therapeutic Vaccines (in vivo dendritic cell activation)

详细技术说明
None
*Abstract
Preventive vaccines, usually composed of priming and booster doses, have proven effective in controlling multiple infectious diseases. In contrast, the efficacy of current therapeutic vaccines remains low. Two long-recognized but poorly understood phenomena in vaccine biology include the requirement for delayed application of booster doses of vaccines in order to achieve effective secondary T cell expansion. The requirement for delayed second exposure to antigen is difficult to meet in the settings of therapeutic vaccination, where in contrast to the preventive vaccines, the pathogen-relevant antigens are already present within the host. The current invention targets a key mechanism of the inability of vaccines to act in the therapeutic settings and proposes to use small molecule approach to restore the effectiveness of vaccines in therapeutic settings, in cancer and established infectious diseases, including AIDS, tuberculosis, leprosy, cytomegalia, herpes simplex, herpes zoster, EBV, Hepatis B and C or established HPV infections, that often constitute premalignant conditions, or to develop effective therapeutic vaccines to such global threats as influenza, SARS, malaria, of leishmaniasis. The proposed invention allows not only the development of new therapeutic vaccines against cancer and established infections, but can also allow the conversion of the existing protective vaccines into therapeutic ones, minimizing the R&D costs of prospective licensees.Applications1. immunotherapy of cancer2. immunotherapy of chronic infections (including HIV, tuberculosis, leprosy, leishmaniasis, hepatitis B and C, cytomegalia, EBV, Herpes simplex infections, established HPV infections and related premalignant states, influenza and related diseases, SARS, leishmaniasis, tuberculosis, leprosy, malaria)
*Principal Investigation

Name: Pawel Kalinski, Assistant Professor of Surgery

Department: Med-Surgery

国家/地区
美国

欲了解更多信息,请点击 这里
移动设备